​

Grace Therapeutics Ownership | Who Owns Grace Therapeutics?

OverviewRevenueFinancialsChart

Grace Therapeutics Ownership Summary

Grace Therapeutics is owned by 23.97% institutional investors, 38.39% insiders, and 37.64% retail investors. Nantahala capital management is the largest institutional shareholder, holding 7.40% of GRCE shares.

GRCE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGrace Therapeutics23.97%38.39%37.64%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management1.18M7.40%$3.50M
Aigh capital management1.13M7.09%$3.35M
Stonepine capital management292.50K1.84%$868.73K
Adar1 capital management176.63K1.11%$524.58K
Palumbo wealth management48.54K0.30%$144.17K
Millington financial advisors20.00K0.13%$67.00K
National bank of canada /fi/2.72K0.02%$8.07K
Activest wealth management104.000.00%$309.00
Jones financial companies lllp29.000.00%$86.00
Jpmorgan chase---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management1.13M1.51%$3.35M
Stonepine capital management292.50K0.85%$868.73K
Nantahala capital management1.18M0.14%$3.50M
Adar1 capital management176.63K0.08%$524.58K
Palumbo wealth management48.54K0.04%$144.17K
Millington financial advisors20.00K0.03%$67.00K
Activest wealth management104.000.00%$309.00
National bank of canada /fi/2.72K-$8.07K
Jpmorgan chase---
Jones financial companies lllp29.00-$86.00

Top Buyers

HolderShares% AssetsChange
Millington financial advisors20.00K0.03%20.00K
Palumbo wealth management48.54K0.04%2.53K
Jones financial companies lllp29.00-29.00
Nantahala capital management1.18M0.14%-
Activest wealth management104.000.00%-

Top Sellers

HolderShares% AssetsChange
Aigh capital management1.13M1.51%-193.88K
Adar1 capital management176.63K0.08%-166.88K
Stonepine capital management292.50K0.85%-2.05K
Jpmorgan chase---15.00
National bank of canada /fi/2.72K--2.00

New Positions

HolderShares% AssetsChangeValue
Millington financial advisors20.00K0.03%20.00K$67.00K
Jones financial companies lllp29.00-29.00$86.00

Sold Out

HolderChange
Jpmorgan chase-15.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252017.65%3,816,908-5.15%231.96%6-25.00%7-
Mar 31, 20251713.33%4,024,09292.74%3410.62%8-42.86%7600.00%
Dec 31, 2024151400.00%2,087,880117.58%1826.09%141300.00%1-
Sep 30, 20241-959,571-8-1---

GRCE Ownership FAQ

Who Owns Grace Therapeutics?

Grace Therapeutics shareholders are primarily institutional investors at 23.97%, followed by 38.39% insiders and 37.64% retail investors. The average institutional ownership in Grace Therapeutics's industry, Biotech Stocks , is 304.14%, which Grace Therapeutics falls below.

Who owns the most shares of Grace Therapeutics?

Grace Therapeutics’s largest shareholders are Nantahala capital management (1.18M shares, 7.40%), Aigh capital management (1.13M shares, 7.09%), and Stonepine capital management (292.5K shares, 1.84%). Together, they hold 16.32% of Grace Therapeutics’s total shares outstanding.

Does Blackrock own Grace Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Grace Therapeutics.

Who is Grace Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Grace Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.51% of its assets in 1.13M Grace Therapeutics shares, valued at 3.35M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools